Advanced Medicine

Can digital tools help cell and gene therapy evolve?

Check out our video interview covering decentralized manufacturing and more.

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?

What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?

Pharma depends on academia, but that relationship can become better… and more fluid

Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies

Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?